BNP Paribas Financial Markets
SLDB icon

BNP Paribas Financial Markets’s Solid Biosciences SLDB Stock Holding History

BNP Paribas Financial Markets’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
108,212
-108,984
-50% -$826K ﹤0.01% 3270
2026
Q1 		$1.56M Buy
217,196
+142,566
+191% +$916K ﹤0.01% 2821
2025
Q4 		$421K Buy
74,630
+1,600
+2% +$8.67K ﹤0.01% 3664
2025
Q3 		$451K Buy
73,030
+61,839
+553% +$362K ﹤0.01% 3593
2025
Q2 		$54.5K Sell
11,191
-9,883
-47% -$34.9K ﹤0.01% 4231
2025
Q1 		$78K Sell
21,074
-23,043
-52% -$98.7K ﹤0.01% 4132
2024
Q4 		$176K Buy
+44,117
New +$242K ﹤0.01% 3942
2022
Q4 		– Sell
-206
Closed -$1.44K – 4540
2022
Q3 		$1.44K Sell
206
-502
-71% -$5.06K ﹤0.01% 4385
2022
Q2 		$6.53K Buy
708
+170
+32% +$1.77K ﹤0.01% 3796
2022
Q1 		$9.69K Sell
538
-1,056
-66% -$18.6K ﹤0.01% 3807
2021
Q4 		$41.8K Buy
1,594
+600
+60% +$18.3K ﹤0.01% 3768
2021
Q3 		$35.6K Buy
994
+561
+130% +$23.8K ﹤0.01% 3583
2021
Q2 		$23.8K Sell
433
-290
-40% -$19.2K ﹤0.01% 3487
2021
Q1 		$59.9K Buy
723
+329
+84% +$36.4K ﹤0.01% 3552
2020
Q4 		$44.8K Sell
394
-40
-9% -$2.53K ﹤0.01% 3607
2020
Q3 		$13.2K Buy
434
+262
+152% +$10K ﹤0.01% 3923
2020
Q2 		$7.55K Sell
172
-227
-57% -$9.43K ﹤0.01% 3833
2020
Q1 		$14.3K Buy
399
+252
+171% +$12.5K ﹤0.01% 3976
2019
Q4 		$9.79K Buy
147
+7
+5% +$772 ﹤0.01% 4128
2019
Q3 		$21.7K Buy
140
+50
+56% +$5.66K ﹤0.01% 3919
2019
Q2 		$7.75K Sell
90
-79
-47% -$8.62K ﹤0.01% 4160
2019
Q1 		$23.3K Buy
+169
New +$42.3K ﹤0.01% 3859
2018
Q4 		– Sell
-19
Closed -$13.5K – 4409
2018
Q3 		$13.5K Hold
19
– – ﹤0.01% 3607
2018
Q2 		$10.2K Sell
19
-94
-83% -$28.9K ﹤0.01% 3772
2018
Q1 		$12.7K Buy
+113
New +$38.2K ﹤0.01% 3992

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BNP Paribas Financial Markets's SLDB Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Solid Biosciences (SLDB) stake by 50% in Q2 2026, selling an estimated $826K and leaving 108,212 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3270.

BNP Paribas Financial Markets first reported a position in SLDB in Q1 2018 and has held it in 25 quarters since. The position peaked at $1.56M in Q1 2026. 145 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • BNP Paribas Financial Markets held 108,212 shares of Solid Biosciences worth $1.08M as of Q2 2026.
  • BNP Paribas Financial Markets sold 108,984 Solid Biosciences shares in Q2 2026, an estimated $826K.
  • Solid Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3270 holding.
  • BNP Paribas Financial Markets first reported a position in Solid Biosciences in Q1 2018 and has held it in 25 quarters since.
  • BNP Paribas Financial Markets's Solid Biosciences position peaked at $1.56M in Q1 2026.
  • 145 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.